Webinar Series of the Chinese Antibody Society
We don't have any active meetings as of now. New meetings will show up here as registration opens. Check back soon!
Sign in to view recordings
03/23/2024
Dr. Li Wan
Antibody-drug conjugates (ADCs) are the latest effective treatment for malignant tumors, following chemotherapy, targeted therapy, and immunotherapy. ADCs combine both the high targeting specificity of antibodies and the potent cytotoxicity of chemotherapy drugs, enabling selective delivery of highly toxic chemotherapy drugs to tumor cells using the high specificity of antibodies, …
01/27/2024
Dr. Frank (Yunsong) Li
Biopharmaceutical molecules such as monoclonal antibodies (mAbs) have complex molecular structure and degradation mechanism. It is important in the early stage of the CMC development to address those degradations by thorough formulation development with advanced analytical tools. This presentation will introduce 1. Key aspects of the mAbs degradation pathway in …
12/16/2023
Dr. Yarong Liu
This lecture will revolve around four key points: the unique advantages of TIL in the treatment of solid tumors compared with other cell therapies; clinical progress of TIL therapy in treatment of different types of solid tumors in recent years; Grit Bio's efforts on promoting the clinical translation of TIL …
11/18/2023
Dr. Zhisong (Sean) Qiao, Languang Shi
The first part of this webinar by Dr. Qiao will provide an overview of veterinary therapeutic antibody development history, discuss the approved products on the market, and outline the general development process. The second part of this webinar by Dr. Shi will provide a concise overview of the current status …